- Home
- Equipment
- north america
- protein therapeutic
Show results for
Refine by
Applications
- Potential Functional Cures for Patients with Chronic Diseases
- Shielded Living Therapeutics Cell for Lysosomal Diseases
- Shielded Living Therapeutics Cell for Diabetes
- Shielded Living Therapeutics Cell for Rare Blood Disorders
- Pipeline for Infectious Diseases
- Pipeline for Immuno-Oncology
- Pipeline for Precision Medicine
Protein Therapeutic Equipment Supplied In North America
15 equipment items found
Manufactured by:Aptevo Therapeutics based inSeattle, WASHINGTON (USA)
ADAPTIR-FLEX technology extends advantages of ADAPTIR technology to create protein therapeutics with varied specificity and valency and potentially new modes of ...
by:Ainovo Biotech Inc. based inSacramento, CALIFORNIA (USA)
AIGenus leverages deep learning algorithms, high performance computing, and biophysical simulations to custom design highly-specific, patentable - proteins for therapeutic and diagnostic purposes. It's protein generation, driven by cutting-edge Machine ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Our Carboxyl Terminal Peptide (CTP) technology is used to extend the half-lives of pharmacologically active proteins. CTP uses recombinant technology to fuse a short, naturally occurring 28 amino acid sequence (a CTP) to a pharmacologically active protein which results in slower excretion of the therapeutic protein, thus, ...
by:Eli Lilly and Company based inIndianapolis, INDIANA (USA)
Our Shielded Living Therapeutics platform combines advanced cell engineering with innovations in biocompatible materials, potentially enabling our products to produce a wide range of therapeutic molecules that may be missing or deficient in the body, including proteins, enzymes or other therapeutic ...
by:Theradaptive based inFrederick, MARYLAND (USA)
With our innovative protein-engineering technology, we transform proteins into material-binding ...
Manufactured by:ASC Therapeutics based inMilpitas, CALIFORNIA (USA)
Genome editing technologies enables permanent modifications to the genome by harnessing the activities of certain enzymes (e.g. nucleases and integrase) and invoking DNA repair mechanisms at specific locations in the genome. As a therapeutic modality, genome editing can correct a defective gene, disrupt a deleterious gene, or target a therapeutic gene to a ...
by:Sutro Biopharma Inc. based inSouth San Francisco, CALIFORNIA (USA)
Conventional methods for expressing proteins utilize cell lines originating from bacteria, yeast, insects, plants, or mammals. Because these methods require intact, functioning cells, the biochemical and biophysical parameters under which proteins are produced using these methods are inherently limited, often failing to produce many proteins and ...
Manufactured by:Solarvest BioEnergy Inc. based inSummerville, PRINCE EDWARD ISLAND (CANADA)
The Company has promising laboratory results in hand for our first mid-term target, the expression of therapeutic proteins in algae. The company has used its proprietary technology to produce the highest published amounts of therapeutic proteins from algae, and is using this technology to produce Bone Morphogenetic ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make antibodies and other biologics at a cost that allows for daily, high-dose, oral and topical delivery. Our current programs target markets that are enormous, the treatment ...
Manufactured by:Phyton Biotech Ltd based inDelta, BRITISH COLUMBIA (CANADA)
Phyton Biotech develops and applies sustainable and “green” chemistry manufacturing solutions for phytochemicals using PCF®, serving the Pharmaceutical, Traditional Chinese Medicine (TCM), Cosmetic, Agricultural and Food Ingredient ...
Manufactured by:SiO2 Materials Science based inAuburn, ALASKA (USA)
We provide a common drug contact surface starting at the research and pre-clinical drug development phases, through clinical trials, and on through to commercial ...
Manufactured by:SiO2 Materials Science based inAuburn, ALASKA (USA)
We provide a common drug contact surface starting at the research and pre-clinical drug development phases, through clinical trials, and on through to commercial ...
Manufactured by:Recursion based inSalt Lake City, UTAH (USA)
Turning drug discovery into a search problem; Central to our mission is the Recursion Operating System (OS), an integrated, multi-faceted system for generating, analyzing and deriving insight from massive biological and chemical datasets to industrialize drug discovery composed ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, ...